Deere & Company’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-7,173
Closed -$226K 224
2016
Q3
$226K Sell
7,173
-7,353
-51% -$214K 0.01% 944
2016
Q2
$408K Sell
14,526
-37,569
-72% -$1.47M 0.02% 744
2016
Q1
$1.89M Sell
52,095
-105
-0.2% -$3.71K 0.1% 214
2015
Q4
$2.09M Buy
52,200
+888
+2% +$31K 0.12% 168
2015
Q3
$1.46M Buy
+51,312
New +$1.69M 0.09% 274
2015
Q2
Sell
-22,356
Closed -$643K 1014
2015
Q1
$643K Buy
22,356
+11,918
+114% +$342K 0.03% 533
2014
Q4
$284K Buy
+10,438
New +$249K 0.02% 763
2014
Q2
Sell
-28,987
Closed -$733K 966
2014
Q1
$733K Buy
+28,987
New +$732K 0.04% 488

Other funds holding EBS

Deere & Company's EBS Position: Q4 2016 in Review

Deere & Company sold out of Emergent Biosolutions (EBS) in Q4 2016, closing a stake of 7,173 shares — an estimated $226K sold.

Deere & Company first reported a position in EBS in Q1 2014 and held it in 8 quarters. The position peaked at $2.09M in Q4 2015. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • Deere & Company reported no remaining Emergent Biosolutions position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 7,173 Emergent Biosolutions shares in Q4 2016, an estimated $226K.
  • Deere & Company first reported a position in Emergent Biosolutions in Q1 2014 and held it in 8 quarters.
  • Deere & Company's Emergent Biosolutions position peaked at $2.09M in Q4 2015.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.